Eli Lilly CEO Dave Ricks Talks Fighting Obesi...

White House Council of Economic Advisers Chairman Chris Phelan states the October CPI report was "not a good number," and inflation came in hot. But he still says raising interest rates by 50 basis points would be premature. He speaks with Bloomberg's Dani Burger and Isabelle Lee ...  Show more

Federal Reserve Governor Christopher Waller on Tuesday lit up debate around a possible half-percentage-point interest rate increase by the central bank in December after inflation data came in hotter than expected. PIMCO Economist Tiffany Wilding discusses Waller's comments and r ...  Show more

Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see ...  Show more

Nicolai Tangen meets with David Ricks, CEO of Eli Lilly, for a discussion about the pharmaceutical giant's remarkable journey. At the forefront is Eli Lilly's breakthrough work with weight reduction drugs, which are showing promise far beyond their original ...

Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ...  Show more